Method for inducing conversion of domestic dog skin fibroblasts into pluripotent stem cells

By using lentiviral reprogramming method to induce skin fibroblasts in domestic dogs in canines, the reprogramming efficiency and differentiation ability of pluripotent stem cells is improved, and the inefficiency and differentiation ability of canine pluripotent stem cells in the prior art is solved. The problem of immaturity has achieved efficient preparation and application of pluripotent stem cells.

CN119020415APending Publication Date: 2024-11-26KUNMING INST OF ZOOLOGY CHINESE ACAD OF SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310586227.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-23
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The culture efficiency and quality of canine-induced pluripotent stem cells in the prior art have low efficiency and quality, resulting in limited application in biomedical research, especially in terms of differentiation ability and risk of immune rejection.

Method used

A method to induce the transformation of skin fibroblasts into pluripotent stem cells in domestic dogs, including isolation and culture, Mycoplasma detection, lentivirus preparation and infection induction, and repeated infection infection of skin fibroblasts in domestic dogs using pLentG-KOSM lentivirus, through optimization induction Culture medium and culture conditions improve reprogramming efficiency and cell differentiation ability.

Benefits of technology

It significantly improved the reprogramming efficiency of canine pluripotent stem cells to reach 0.012%, and can obtain pluripotent stem cells within 7 days, possesses the ability of stem cells to differentiate into neural progenitor cells, solving the low efficiency in the existing technology and the problem of immature differentiation ability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119020415A_ABST
    Figure CN119020415A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of cell engineering, and discloses a method for inducing conversion of skin fibroblasts of domestic dogs into pluripotent stem cells. The method comprises the following steps: carrying out isolated culture on the skin fibroblasts of the domestic dogs, after determining that the fibroblasts are not infected by mycoplasma, preparing lentivirus, determining pLentG-KOSM titer, and after lentivirus infection, carrying out culture by using a pluripotent stem cell induction culture solution to obtain the induced pluripotent stem cells. The lentivirus of pLentG-KOSM is utilized for the first time, adult dog skin fibroblasts are reprogrammed into the dog pluripotent stem cells, the culture efficiency is greatly improved, the dog pluripotent stem cells have the characteristics of embryonic stem cells and the trigerm differentiation capacity of stem cells, and the dog pluripotent stem cells cultured through the method can also be induced into neural progenitor cells. According to the method, the reprogramming efficiency reaches 0.012%, and the reprogramming efficiency is improved by about 15 times compared with 0.0007% of the reprogramming efficiency of the dog skin fibroblasts in the prior art.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of cell engineering and relates to a method for inducing canine skin fibroblasts into pluripotent stem cells. Background Art

[0002] The reason why stem cells are called "universal cells" depends on the multidirectional differentiation mechanism of stem cells. Stem cells have the ability to differentiate into any type of cell. By differentiating into different cells, they can then form various organs and tissues. The germ layer differentiation ability of stem cells is the first step in the multidirectional differentiation mechanism. In the existing technology, some cultured stem cells have not been identified for their germ layer differentiation ability, resulting in poor applicability in practical applications. Induced pluripotent stem cells (iPSCs) are introduced by exogenous genes to induce reprogramming of differentiated somatic cells, acquire stem cell characteristics, and have the potential for unlimited self-renewal and differentiation into multiple somatic cell lineages, thereby providing a platform for the treatment of various diseases through regenerative medicine, disease modeling and drug discovery.

[0003] In 2006, Yamanaka used retrovirus to mediate four pluripotent transcription factors (OCT4, Sox2, Klf4, c-Myc) to reprogram mouse fibroblasts into pluripotent stem cells that are the same as embryonic stem cells. After that, more and more researchers conducted related studies on multiple species and successfully established induced pluripotent stem cell lines in species such as humans, macaques, rats, pigs, cattle, and sheep. The establishment of iPSCs no longer requires embryos or fetuses as a source of material, so it has more advantages in ethics. The use of somatic cells to complete reprogramming also solves the problem of immune rejection in stem cell therapy, and has great application prospects in disease treatment, pathological research, drug screening, and other aspects. From the establishment of human induced pluripotent stem cells in 2007 to the first use in clinical medicine in 2014, researchers used hiPSC-derived retinal pigment epithelial cells for related patients, and the application prospects of iPSC in the field of regenerative medicine are becoming more and more extensive. However, the safety of using induced pluripotent stem cells for cell therapy needs to be studied. The treatment evaluation of iPSC-derived cells is subject to extremely strict government regulations, and it is difficult to verify them in humans. This requires other large animals to verify. Compared with laboratory mice or rats, domestic animals such as dogs, pigs and cattle, which are physiologically similar to humans, are considered to be excellent models for long-term experiments in regenerative medicine and biomedical research. iPSCs also need more research in multiple strains and species to ultimately prove and develop safe, non-immunogenic induced pluripotent stem cells that can be used for regenerative medicine. Among the many large species, dogs are the most commonly used species for transplantation, spanning more than 40 years, and among the more than 400 canine genetic diseases confirmed, about half of them are similar to humans, including cardiomyopathy and muscular dystrophy, Alzheimer's disease, retinal atrophy, muscular dystrophy, cancer, obesity, cardiovascular disease and diabetes. Another very critical reason for the need for large species to study iPSCs is in terms of differentiation ability. iPSCs have been shown to differentiate into a variety of tissues of all three germ layer cells, while ESCs are still difficult to produce specific cell types with high purity and high quality. The advantage of canine iPSCs (ciPSCs) over ESCs is that, due to their patient specificity, they are more suitable for transplantation back into the research animals from which they are derived without having to address immune rejection issues. In addition, the production of ciPSCs from individuals with genetic diseases allows for the dissection of events at the genomic, proteomic, and epigenetic levels involved in the disease process in vitro, and ultimately for modeling gene therapy and testing drug efficacy. In addition, induced pluripotent stem cells can be used for drug screening, and the required research materials can be obtained directly from patients, without ethical restrictions, and with abundant cell sources. The obtained disease iPSCs and their differentiated cells have been widely used in pathological mechanism research, drug screening and safety testing, cell therapy research, etc.

[0004] As mentioned above, domestic dogs are considered to be human companions and family members. They live in the same environment as humans, are deeply involved in human activities and social life, and suffer from the same diseases as humans. In addition, dogs have a relatively long lifespan, and the mid-term treatment effect and safety of related diseases can be evaluated. Therefore, as the earliest domesticated domestic animals, domestic dogs have great similarities with humans in terms of behavior, disease types, and phenotypes, and are one of the model animals for studying mental illness and behavioral research. However, compared with the research on iPSCs in humans and mice, the potential for the development and application of this technology in dogs is still limited.

[0005] In recent years, the establishment of canine iPSCs has also attracted the attention of many scholars. Although there have been reports of the successful establishment of canine iPSCs, the reprogramming factors used in the canine somatic cell reprogramming system are all "OSKM", and the species of exogenous genes are humans and mice. Human transcription factors are relatively more commonly used in canine reprogramming. There are also a few studies that use canine transcription factors for reprogramming. The results are not completely unified, and whether they can be applied to biomedical research also needs further verification. In the identification of induced pluripotent stem cells, the identification used in the early publication of Shinya Yamanaka is similar to the identification of embryonic stem cells. The identification and characterization of iPSCs can be completed through cell morphology, alkaline phosphatase staining, pluripotency marker expression, lineage gene analysis, and in vivo teratoma. However, the current canine induced pluripotent stem cell system is not yet mature, the induced pluripotent stem cells produced have different morphologies, and relatively few cells can be produced. Tsukamoto et al. established ciPSCs from canine embryonic fibroblasts (CEFs) and peripheral blood mononuclear cells (PBMCs); however, although canine peripheral blood mononuclear cells (PBMCs) are easy to obtain, their iPSC reprogramming efficiency is very low. In these ciPSCs culture systems, mouse-derived feeder cells, such as mouse embryonic fibroblasts (MEFs), are used, but these animal components may increase the risk of immune rejection when used clinically. In addition, in traditional culture systems, ciPSCs require skilled techniques and a lot of time and effort. Some people have also successfully generated ciPSCs from canine embryonic fibroblasts (CEFs) and canine PBMCs using the viral vector SeVdp (KOSM) 302L, but the efficiency of iPSC primary colony formation is very low, and cipscs cannot differentiate into the three germ layers in vivo. Deanne J. Whitworth et al. used lentivirus expressing human OCT4, SOX2, KLF4, c-MYC, NANOG and LIN28 to reprogram adult canine dermal fibroblasts into ciPSCs, but the reprogramming efficiency was only 0.0007%. In 2018, the reprogramming efficiency of canine embryonic fibroblasts using Sendai virus was 0.02%. In some reports, ciPSCs showed deformities and immature structures of the three germ layer tissues, suggesting that current culture conditions are insufficient to maintain the full pluripotency of ciPSCs. Existing technologies lack strong and efficient canine ciPSC generation and maintenance. Summary of the invention

[0006] In view of this, the purpose of the present invention is to provide a method for inducing the conversion of canine skin fibroblasts into pluripotent stem cells, improve the culture efficiency and quality of canine ciPSCs, provide a new research object for comparative studies on genetic evolution of canines, and also provide a new idea for canine domestication research, human disease research, and new drug development.

[0007] The technical solution of the present invention is as follows:

[0008] A method for inducing the transformation of canine skin fibroblasts into pluripotent stem cells comprises the following steps:

[0009] S1 Isolation and culture of canine skin fibroblasts;

[0010] S2 Mycoplasma testing of canine skin fibroblasts confirmed that the fibroblasts were free of mycoplasma infection;

[0011] S3 lentivirus preparation and pLentG-KOSM titer determination;

[0012] S4 Lentivirus infection to induce canine pluripotent stem cell formation: The F2 generation canine skin fibroblasts obtained in step S1 are repeatedly infected with the lentivirus containing pLentG-KOSM prepared in step S3, and after infection, they are cultured with a pluripotent stem cell induction culture medium to obtain induced pluripotent stem cells; the pluripotent stem cell induction culture medium is divided into an early pluripotent stem cell culture medium and a late pluripotent stem cell culture medium;

[0013] S5 detects and identifies the induced pluripotent stem cells obtained by S4.

[0014] Furthermore, the specific steps of inducing the formation of canine pluripotent stem cells by S4 lentivirus infection are:

[0015] S41. Take F2 canine skin fibroblasts and add 5×10 4 The cells were seeded in a 6-well culture plate and cultured for 12 h. The prepared lentivirus containing pLentG-KOSM was used to infect canine skin fibroblasts at an MOI of 20, and the infection was repeated 24 h later;

[0016] S42. After infection, 2×10 4 Plated on 6-well plates treated with Matrigel in advance, cultured in RM medium 24 hours after infection;

[0017] S43. 2-7 days after infection, replace the previous pluripotent stem cell culture medium with the culture medium, and change the medium every 48 hours;

[0018] S44. 7-21 days after infection, switch to late pluripotent stem cell culture medium, and change the medium every 48 hours until embryonic stem cell-like cell clones appear. Use a mouth pipette to pick up the clones and expand the culture in a 48-well plate treated with matrix gel.

[0019] Furthermore, the isolation and culture steps of S1 canine skin fibroblasts are as follows:

[0020] S11. Collection of skin tissue from domestic dogs:

[0021] The animals were anesthetized, the skin of the buttocks was disinfected with 75% alcohol, the epidermal hair was cut as much as possible, a small piece of skin tissue was cut, the cut part was disinfected again, and the tissue was soaked in 75% alcohol for 10 seconds, and then washed three times in 1× PBS containing 5% double antibody, and the disinfected and washed tissue was placed in AQIX tissue preservation solution containing 2% double antibody and transported back to the laboratory at 4°C;

[0022] S12. Tissue pretreatment: After the tissue is transported back to the laboratory, it is washed twice in 1×PBS containing 2% double antibody in a biological safety cabinet, the epidermal hair and fat layer are scraped off with a blade, and the tissue is chopped with sterile scissors;

[0023] S13. Enzyme digestion method to obtain canine skin fibroblasts:

[0024] Place the chopped tissue in step S12 into a 50ml centrifuge tube, add about 5 times the volume of 0.25% trypsin digestion solution, and digest in a 37°C water bath for 30-90min. During this period, shake the centrifuge tube several times to ensure that the tissue blocks are fully digested; terminate the digestion with complete cell culture medium containing serum, let it stand for 10min, pass through 200 and 400 mesh cell sieves in turn, centrifuge the suspension at 1000rpm for 10min, resuspend and wash once with DMEM basal culture medium, and centrifuge at 1000rpm for 10min; resuspend with 1ml complete cell culture medium, inoculate in a T25 culture flask, culture with cell culture medium, and replace with fresh culture medium every 48 hours until the cells are full.

[0025] Furthermore, the specific steps of preparing the S3 lentivirus and determining the titer of pLentG-KOSM are as follows:

[0026] S31. Resuscitate 293T cells, plate them in 100 mm culture dishes, and transfect when the cell density reaches about 60%. Replace with fresh culture medium before transfection.

[0027] S32. The plasmid and transfection reagent were mixed at a ratio of 1:1.5-1:4 and added to 293T cells. Six hours after transfection, the transfection reagent was washed away and replaced with fresh culture medium;

[0028] S33. Collect the virus supernatant 48 and 72 hours after transfection, centrifuge at 1000 rpm for 10 min, and filter the supernatant through a 0.45 uM cell filter;

[0029] S34.1 volume of 5×PEG8000 was gently mixed with 4 volumes of viral supernatant obtained from S33 and incubated at 4°C overnight;

[0030] S35.4500g, centrifuge at 4℃ for 20min, discard the supernatant, resuspend in DMEM basal culture medium at 2-3 times the volume of the pellet, aliquot the virus into 100ul, and store at -80℃ for later use;

[0031] S36.293T cells were collected at 5×10 4 Plated in 12-well plates, virus infection was performed after 24 h, with a culture volume of 1 ml per well;

[0032] S37. The virus solution was added at a volume of 10, 50, 100, and 200 ul to infect 293T cells. After 48 hours of infection, the 293T cells infected with different pLentG-KOSM virus additions were collected, the cell fluorescence was detected, and the average virus titer was calculated using the formula: (293TGFP% × total number of 293T cells) ÷ added virus volume.

[0033] Preferably: the canine skin fibroblast culture medium has the following components: 15% FBS, DMEM basal medium, and 1-2% double antibody.

[0034] Preferably, the aforementioned early pluripotent stem cell culture medium comprises: 10-20% FBS, 0.5-1.5% MEM NEAA, 0.5-1.5% glutamine, 10-20 ng / ml FGF, 10-20 ng / ml LIF, and DMEM basal medium.

[0035] Preferably, the components of the early pluripotent stem cell culture medium include: 10% FBS, 1% MEM NEAA, 1% glutamine, 10 ng / ml FGF, 10 ng / ml LIF, and DMEM basal medium.

[0036] Preferably, the late pluripotent stem cell culture medium comprises: 20% 5×Supplement, 10-20ng / ml FGF, 10-20ng / ml LIF, 0.1-0.5uM Pifithrin-μ, 0.5-1uM A83-01, 0.5-1uM Y27632, 0.5-1uM PD0325901, 2-5uM CHIR99021, 200-300uM Sodium Butyrate, and mTeSR basal medium.

[0037] Preferably, the late pluripotent stem cell culture medium comprises: 20% 5×Supplement, 10 ng / ml FGF, 10 ng / ml LIF, 0.3 uM Pifithrin-μ, 0.5 uM A83-01, 0.5 uM Y27632, 0.5 uM PD0325901, 3 uM CHIR99021, 250 uM Sodium Butyrate, and mTeSR basal medium.

[0038] Compared with the prior art, the present invention has the following beneficial effects:

[0039] 1) The skin fibroblasts in the present invention are derived from the epidermis of adult domestic dogs, which solves the problem that primary culture of hairy tissue is easy to be contaminated and difficult to handle. The present invention is simple to operate, and the obtained skin fibroblasts have strong vitality and high purity. The virus prepared by the present invention has high titer and strong infection efficiency.

[0040] 2) The present invention uses the pLentG-KOSM lentivirus for the first time to reprogram adult canine skin fibroblasts into canine pluripotent stem cells, with a reprogramming efficiency of 0.012%, which is nearly 15 times higher than the efficiency of 0.0007% of canine skin fibroblasts reprogramming in the prior art.

[0041] 3) The present invention improves the culture method of induced pluripotent stem cells and the pluripotent stem cell induction medium, and can obtain pluripotent stem cells in 7 days, which greatly improves the culture efficiency compared with the existing technology (starting from 12 days). The culture efficiency is greatly improved, and the cells have the characteristics of embryonic stem cells, have the ability to differentiate into the three germ layers of stem cells, and can differentiate into neural progenitor cells. BRIEF DESCRIPTION OF THE DRAWINGS

[0042] Figure 1 This is a microscopic display of the morphology of canine skin fibroblasts.

[0043] Figure 2 This is the growth curve of canine skin fibroblasts.

[0044] Figure 3 This is the karyotype result of canine skin fibroblasts.

[0045] Figure 4 This is the result of immunofluorescence identification of canine skin fibroblasts.

[0046] Figure 5 This is the result of mycoplasma detection in canine skin fibroblasts.

[0047] Figure 6 Fluorescence image of virus infection.

[0048] Figure 7 This is a morphological diagram of induced pluripotent stem cells of domestic dog.

[0049] Figure 8 This is a diagram showing the results of alkaline phosphatase identification in canine induced pluripotent stem cells.

[0050] Fig. 9 This is the result of immunofluorescence identification of canine induced pluripotent stem cells.

[0051] Fig.10 This is a graph showing the expression results of stemness genes in canine induced pluripotent stem cells.

[0052] Fig.11 This is the embryoid body morphology of canine induced pluripotent stem cells.

[0053] Fig.12 This is a diagram showing the identification of the three germ layer differentiation of embryoid bodies of induced pluripotent stem cells from domestic dogs.

[0054] Fig.13 This is a morphological diagram of canine induced pluripotent stem cells when MEF is used as a trophoblast.

[0055] Fig.14 This is a morphological diagram of neural progenitor cells obtained from canine induced pluripotent stem cells.

[0056] Fig.15 This is the result of immunofluorescence identification of neural progenitor cells obtained from canine induced pluripotent stem cells. DETAILED DESCRIPTION

[0057] The object of the present invention is to provide a method for inducing canine skin fibroblasts into pluripotent stem cells, and the method is described in detail through cell morphology, growth curve, karyotype analysis, immunofluorescence identification, alkaline phosphatase identification, embryoid body formation, and three-germ layer differentiation test, but the present invention is not limited to the following specific embodiments.

[0058] Example 1: Isolation and culture of canine skin fibroblasts

[0059] 1. Collection of skin tissue from domestic dogs:

[0060] The animals were anesthetized, the skin of the buttocks was disinfected with 75% alcohol, the epidermal hair was cut as much as possible, a small piece of skin tissue was cut, the cut part was disinfected again, and the tissue was soaked in 75% alcohol for 10 seconds, and then washed three times in 1× PBS containing 5% double antibody. The disinfected and washed tissue was placed in AQIX tissue preservation solution containing 2% double antibody and transported back to the laboratory at 4°C.

[0061] 2. Tissue pre-treatment:

[0062] After the tissue was transported back to the laboratory, it was washed twice in 1×PBS containing 2% double antibody in a biological safety cabinet, the epidermal hair and fat layer were scraped off with a blade, and the tissue was chopped with sterile scissors.

[0063] 3. Enzyme digestion method to obtain canine skin fibroblasts:

[0064] Place the chopped tissue in step 2 in a 50ml centrifuge tube, add about 5 times the volume of 0.25% trypsin digestion solution, and digest in a 37℃ water bath for 90min. During this period, shake the centrifuge tube several times to fully digest the tissue blocks; terminate the digestion with complete cell culture medium containing serum, let it stand for 10min, pass through 200 and 400 mesh cell sieves in turn, centrifuge the suspension at 1000rpm for 10min, resuspend and wash once with DMEM basal medium, and centrifuge at 1000rpm for 10min; resuspend in 1ml complete cell culture medium,

[0065] Inoculate into T25 culture flasks and replace with fresh culture medium every 48 hours until the cells are confluent.

[0066] In this example, the reagents were prepared as follows: 100 ml DMEM canine skin fibroblast complete culture medium: 84 ml DMEM basal medium + 15 ml FBS + 1 ml double antibody. In this example, DMEM culture medium, FBS, trypsin, MEM NEAA, and double antibody were purchased from Gibco.

[0067] Example 2: Morphological observation of canine skin fibroblasts

[0068] In Example 1, when the cell density reached about 80%, the cells were observed and photographed under an inverted microscope. The canine skin fibroblasts grew in a fibrous manner and adhered to the wall. Figure 1 Cell morphology shown.

[0069] Example 3: Plotting of the Growth Curve of Canine Skin Fibroblasts

[0070] 1. Take F1 cells from Example 1, bring the density to about 80%, wash twice with 1×PBS, digest with 0.25% trypsin for 3 min, terminate digestion, centrifuge at 1000 rpm for 3 min, and resuspend the cells in 1 ml of culture medium;

[0071] 2. Take 100ul of the cell suspension, mix it with 100ul 0.4% trypan blue solution, and count it on a counting plate;

[0072] 3. Canine skin fibroblasts were cultured at 1×10 per well. 4 / ml cells were plated on 24-well culture plates, 1ml per well, and cultured in an incubator;

[0073] 4. Randomly select cells from 3 wells every 24 hours, digest them with trypsin into cell suspension and count them. Count each well three times and take the average value.

[0074] 5. Count continuously for 7 days and draw a cell growth curve with cell density as the vertical axis and time as the horizontal axis.

[0075] The results are as follows Figure 2 As shown, the cells all showed S-shaped growth, which was consistent with the changing characteristics of the cell growth kinetics curve.

[0076] In this example, 0.4% trypan blue solution was purchased from Gibco.

[0077] Example 4: Karyotype analysis of canine skin fibroblasts

[0078] 1. Take the F2 cells from Example 1 and place them in a 100 mm culture dish. The density is about 80%. Add colchicine at a final concentration of 0.2 ug / ml and incubate at 37°C for 2-3 hours.

[0079] 2. When the cells are attached to the wall and most of them become round, remove the treatment solution, wash 2-3 times with 1×PBS, digest with 0.25% trypsin for 2 minutes, stop digestion, and centrifuge at 1000 rpm for 10 minutes.

[0080] 3. Discard the supernatant, add 6 ml of preheated 0.075M Kcl hypotonic solution, and incubate in a 37°C water bath for 30 min.

[0081] 4. Add 1 ml of fixative solution for pre-fixation for 5 minutes and centrifuge at 1000 rpm for 10 minutes.

[0082] 5. Discard the supernatant, resuspend in 6 ml of fixative, fix at room temperature for 30 min, and centrifuge at 1000 rpm for 10 min.

[0083] 6. Discard the supernatant, fix for 15 minutes with 6 ml of fixative, and centrifuge at 1000 rpm for 10 minutes.

[0084] 7. Discard the supernatant, fix with 6 ml of fixative three times for 10 min, and centrifuge at 1000 rpm for 2 min.

[0085] 8. Discard the supernatant, resuspend in 0.5 ml of fixative, place 1-2 drops of cell suspension on a pre-cooled slide, and let dry.

[0086] 9. Place the slide upside down in a clean culture dish, pipette 1 ml of Giemsa stain solution and inject it from under the slide, and stain for 10 minutes.

[0087] 10. Wash off the dye with ddH2O, and observe and take pictures under an oil microscope after drying.

[0088] The results are as follows Figure 3 As shown, canine skin fibroblasts contain 39 pairs of chromosomes, including 38 pairs of autosomes + 1 pair of XX chromosomes.

[0089] The reagents in this example are prepared as follows: 0.1 mg / ml colchicine stock solution: 0.1 mg colchicine is dissolved in 1 ml physiological saline and stored at -20°C for later use. 0.075 M Kcl hypotonic solution: 0.28 g Kcl is weighed and dissolved in 50 ml ddH2O, and stored at room temperature for later use. Fixative: 1 volume of glacial acetic acid is mixed with 3 volumes of methanol, and it is prepared before use. Giemsa staining solution: 1 volume of Giemsa stock solution is mixed with 9 volumes of 1× PBS, passed through a 40uM cell sieve, and it is prepared before use. In this example, colchicine, Kcl, glacial acetic acid, and methanol were purchased from Sangon; Giemsa stock solution was purchased from Solebao.

[0090] Example 5: Identification of canine skin fibroblasts by immunofluorescence

[0091] 1. Take the F2 cells from Example 1, inoculate them into a 24-well culture plate and culture them for 48 hours;

[0092] 2. Discard the culture medium, wash 3 times with 1×PBS, and fix with 4% paraformaldehyde at room temperature for 30 min;

[0093] 3. Discard the fixative, wash three times with 1×PBS, and incubate the cells with immunofluorescence permeabilization solution (0.1% 100×Triton) at room temperature for 20 min;

[0094] 4. Discard the permeabilization solution, wash 3 times with 1×PBS, add cell immunofluorescence blocking solution, and incubate at 37℃ for 1h;

[0095] 5. Discard the blocking solution, wash 3 times with 1×PBS, add Vimentin primary antibody (dilution ratio 1:200), and incubate overnight at 4℃ in the dark;

[0096] 6. Recover the primary antibody, wash 3 times with 1×PBS, add Cy3 and FITC secondary antibodies (dilution ratio 1:500), and incubate at room temperature in the dark for 1 hour;

[0097] 7. Recover the secondary antibody, wash three times with 1×PBS, add DAPI solution for counterstaining, and incubate at 37°C in the dark for 30 minutes;

[0098] 8. Recover DAPI, wash 3 times with 1×PBS, add anti-fluorescence quencher, observe the staining results under a fluorescence inverted microscope and take pictures to obtain the immunofluorescence identification results.

[0099] The results are as follows Figure 4 As shown, more than 90% of canine skin fibroblasts positively expressed Vimentin, indicating that the present invention successfully isolated skin fibroblasts. In this example, 4% paraformaldehyde, cell immunofluorescence permeabilization solution, cell immunofluorescence blocking solution, and DAPI were purchased from Beyotime; Vimentin and FITC Goat Anti-Mouse IgG (H+L) were purchased from Abclonal.

[0100] Example 6: Mycoplasma detection in canine skin fibroblasts

[0101] During the cell culture process, mycoplasma contamination cannot be detected by visual methods, and its effect on cell growth is small, so it is often ignored. However, mycoplasma contamination can change the DNA / RNA and protein expression in cells, causing serious impacts on subsequent experiments such as genome sequencing, and can also cause problems such as repeated experimental failures in routine tests. Therefore, it is particularly important to control cell quality in the early stages.

[0102] 1. Take F2 cells from Example 1, culture them for at least 3 days, and take the culture supernatant;

[0103] 2.1ul supernatant and 24ul MycoBlue Buffer, 1ul MycoBlue Enzyme were reacted at 60° for 1h;

[0104] 3. Negative control: water or no sample; positive control: the sample containing mycoplasma in the kit;

[0105] 4. Negative control is purple and positive control is blue.

[0106] The results are as follows Figure 5 As shown, the skin fibroblasts of domestic dogs were purple after testing and had no mycoplasma contamination.

[0107] The mycoplasma detection test kit in this embodiment was purchased from Novazonics.

[0108] Example 7: Preparation of lentivirus and determination of pLentG-KOSM titer

[0109] 1. Resuscitate 293T cells, plate them in a 100 mm culture dish, and transfect when the cell density reaches about 60%. Replace with fresh culture medium before transfection;

[0110] 2. Mix the plasmid and transfection reagent in the following ratio (Table 1-Table 3), add to 293T cells, wash off the transfection reagent 6 hours after transfection, and replace with fresh culture medium;

[0111] 3. Collect the viral supernatant 48 and 72 hours after transfection, centrifuge at 1000 rpm for 10 min, and filter the supernatant through a 0.45 uM cell filter;

[0112] 4.1 volume of 5×PEG8000 and 4 volumes of viral supernatant were gently mixed and incubated at 4°C overnight;

[0113] 5. Centrifuge at 4500g for 20 min at 4°C, discard the supernatant, resuspend in DMEM basal culture medium at 2-3 times the volume of the pellet, aliquot the virus into 100ul portions, and store at -80°C for later use;

[0114] 6.293T cells were cultured at 5×10 4 Plated in 12-well plates, virus infection was performed after 24 h, with a culture volume of 1 ml per well;

[0115] 7. The virus solution was added in amounts of 10, 50, 100, and 200 ul to infect 293T cells. Cell fluorescence was detected 48 hours after infection and the virus titer was calculated using the formula: (293T GFP% × total number of 293T cells) ÷ added virus volume.

[0116] The results are as follows Figure 6As shown in Table 4, 72 hours after transfection, about 80% of the 293T cells had fluorescence intensity. The collected pLentG-KOSM virus infected 293T cells. After 48 hours of infection, the virus titer was 1-3×10 6 TU / mL.

[0117] The reagents in this example are prepared as follows: 5×PEG8000: weigh 100g PEG8000 and dissolve it in 400ml ddH2O, sterilize it at 121℃ and autoclave for 30min, wait until the temperature reaches about 50℃, then weigh 17.532g NaCl and dissolve it, store it at 4℃ for later use after it is completely dissolved. All the established reaction systems produce results.

[0118] In this example, OPTI-MEM was purchased from Gibco; Lipofectamine TM 2000 was purchased from Invitrogen; pLentG-KOSM, pSPAPX2, and pMD2.G were purchased from HonorGene; and PEG8000 was purchased from Bio-Time.

[0119] Table 1 Transfection system 1

[0120]

[0121] Table 2 Transfection system 2

[0122]

[0123] Table 3 Transfection system 3 (OCT4)

[0124]

[0125]

[0126] In transfection system 3, the same amount of SOX2, Klf4, and c-myc were used to replace OCT4, and other conditions remained unchanged.

[0127] from Figure 7 and Fig.10 It can be seen that the comparison effect between the transfection systems is mainly reflected in the positive rate of AP clones in the later stage and the expression level of pluripotent gene mRNA after infection. At the same time, it can be seen that the expression levels of pluripotent marker genes OCT4, SOX2, and NANOG are high. System 1 has the best effect.

[0128] Table 4 Virus infection and titer detection results

[0129] Processing gradients Total number of cells GFP cell number GFP% TU / ml 10 <![CDATA[7.96×10 5 ]]> 0 0 0 50 <![CDATA[6.81×10 5 ]]> <![CDATA[1.22×10 5 ]]> 17.9% <![CDATA[2.4×10 6 ]]> 100 <![CDATA[5.29×10 5 ]]> <![CDATA[1.98×10 5 ]]> 37.4% <![CDATA[2.0×10 6 ]]> 200 <![CDATA[9.35×10 5 ]]> <![CDATA[4.73×10 4 ]]> 50.6% <![CDATA[2.4×10 6 ]]> Mean <![CDATA[2.3×10 6 ]]>

[0130] Example 8: Lentivirus infection induces the formation of canine pluripotent stem cells

[0131] 1. Take F2 cells from Example 1 and add 5×10 4 Cells were seeded in 6-well culture plates and cultured for 12 h, pLentG-KOSM infected cells at an MOI of 20, Fuw-Teto-OSKM and the four factors transfected separately infected cells at 80% of the viral load, and the infection was repeated 24 h later;

[0132] 2. After infection, 2 × 10 fibroblasts were cultured 4 Plated on 6-well plates treated with Matrigel or MEF in advance, cultured in RM medium 24 hours after infection;

[0133] 3. 2-7 days after infection, replace the culture medium with the previous pluripotent stem cell culture medium, and change the medium every 48 hours;

[0134] 4. 7-21 days after infection, change to late pluripotent stem cell culture medium and change the medium every 48 hours until embryonic stem cell-like cell clones appear. Use a mouth pipette to pick the clones and expand them into 48-well plates treated with matrix gel or MEF.

[0135] The results are as follows Figure 7 As shown, pLentG-KOSM has the best effect. After infection of canine skin fibroblasts, multi-factor mTeSR was used to culture for 7 days, and the cell morphology began to change. The cells slowly aggregated and began to form clones. After 14-21 days of culture, a large number of embryonic stem cell-like cell clones were formed, and the reprogramming efficiency was 0.012%. Compared with the existing technology, the virus infection of canine skin fibroblasts obtained by separate transfection of four factors had the worst effect, and almost no clone formation was seen; the effect of the Fuw-Teto-OSKM system was better than the effect of the four-factor separation, but lower than the pLentG-KOSM system, and the number of clones was also very small.

[0136] Compared with MEF coating, the effect of matrix gel is better, and the cell clones basically no longer contain fibroblasts. Compared with matrix gel, the inventors also used MEF as a trophoblast culture result as shown in the figure Fig.13 Compared with Matrigel, the number of cloned cells obtained is small, the cloning area is small, and the AP positive rate is also low. Therefore, the present invention selects Matrigel as the feeder layer.

[0137] In this embodiment, the reagents are prepared as follows:

[0138] 20ug / ml FGF mother solution: 100ug FGF is dissolved in 5ml 1% BSA solution, divided and stored at -20℃ for future use.

[0139] 20ug / ml hLIF stock solution: 100ug hLIF dissolved in 5ml ddH2O, divided into aliquots, and stored at -20℃ for future use.

[0140] 3mM Pifithrin-μ stock solution: 10mg Pifithrin-μ is dissolved in 18.395ml DMSO, divided into aliquots, and stored at -20℃ for future use.

[0141] 1mM A83-01 stock solution: 1mg A83-01 is dissolved in 2.37ml DMSO, divided into aliquots, stored at -20℃ for future use, and used as soon as possible.

[0142] 5 mM Y27632 stock solution: 5 mg Y27632 was dissolved in 4.04 ml DMSO, divided and stored at -20°C until use.

[0143] 0.5mM PD0325901 stock solution: 5mg PD0325901 is dissolved in 20.75ml DMSO, divided and stored at -20℃ for future use.

[0144] 3mM CHIR99021 stock solution: 5mg CHIR9902 is dissolved in 2.9ml DMSO, divided and stored at -20℃ for future use.

[0145] 50mM Sodium Butyrate stock solution: 25mg Sodium Butyrate dissolved in 4.5ml ddH2O, stored at -20℃ for future use. RM culture medium: 43.5ml DMEM basal medium + 5ml FBS + 1% MEM NEAA + 1% glutamine + 1% double antibody

[0146] Early stage pluripotent stem cell culture medium: 10-20% FBS, 0.5-1.5% MEM NEAA, 0.5-1.5% glutamine, 10-20ng / ml FGF, 10-20ng / ml LIF, DMEM basal medium.

[0147] Preferably, 10% FBS, 1% MEM NEAA, 1% glutamine, 10 ng / ml FGF, 10 ng / ml LIF, DMEM basal medium.

[0148] Late pluripotent stem cell culture medium: 20% 5×Supplement, 10-20ng / ml FGF, 10-20ng / ml LIF, 0.1-0.5uM Pifithrin-μ, 0.5-1uM A83-01, 0.5-1uM Y27632, 0.5-1uM PD0325901, 2-5uM CHIR99021, 200-300uM Sodium Butyrate, mTeSR basal medium.

[0149] Preferably, late pluripotent stem cell culture medium: 39.84 ml mTeSR TM 1basal culture medium+10ml 5×Supplement+10ng / mlFGF+10ng / mlhLIF+0.3uM Pifithrin-μ+0.5uM A83-01+0.5uM Y27632+0.5uM PD0325901+3uM CHIR99021+250uM Sodium Butyrate.

[0150] In this example, Matrigel, mTeSR TM 1Pluripotent stem cell culture medium was purchased from STEMCELL; FGF and hLIF were purchased from peprotech; A83-01, Y27632, and CHIR99021 were purchased from MCE; Pifithrin-μ, CHIR99021, and SodiumButyrate were purchased from Selleck.

[0151] Example 9: Alkaline phosphatase and immunofluorescence detection of induced pluripotent stem cells

[0152] 1. One portion of the cells selected in Example 7 was used for alkaline phosphatase detection, and the other portion was used for pluripotent gene detection;

[0153] 2. Alkaline phosphatase detection: remove the culture medium, wash 2-3 times with 1×PBS, fix with 4% paraformaldehyde at room temperature for 15 minutes, discard the fixative, wash 2-3 times with 1×PBS, add the reaction solution, incubate in the dark until color is developed, discard the reaction solution, wash with ddH2O to terminate the reaction, examine under a microscope and take pictures;

[0154] 3. Pluripotent stem cell gene immunofluorescence detection: The experimental steps are as in Example 5; the primary antibodies are OCT4, Sox2, Nanog, and SSEA-1,

[0155] The secondary antibody was Cy3 Goat Anti-Mouse IgG (H+L).

[0156] The results are as follows Figure 8 and Fig. 9 As shown, it shows that the canine embryonic stem cell-like cell clones induced by the pLentG-KOSM system are positive for alkaline phosphatase after staining, a small number of cells in the four-factor separate transfection induction system are weakly positive, and the Fuw-Teto-OSKM system is not successfully stained. The immunofluorescence detection of canine induced pluripotent stem cells induced by the pLentG-KOSM system positively expresses OCT4, Sox2, Nanog, and SSEA-1, indicating that the present invention successfully induces canine skin fibroblasts into pluripotent stem cells.

[0157] Table 5 Reaction solution system

[0158] Reagents volume Alkaline phosphatase colorimetric buffer 3ml BCIP solution (300×) 10μl NBT solution (150×) 20μl Staining reaction solution 3.03ml

[0159] In this example, the BCIP / NBT alkaline phosphatase detection kit was purchased from Beyotime Pharmaceuticals; OCT4, Sox2, Nanog, and SSEA-1 antibodies were purchased from Santa Cruz Pharmaceuticals.

[0160] Example 10: Detection of stemness gene expression in induced pluripotent stem cells

[0161] The cells infected for 2 days in Example 7 were subjected to stemness gene expression detection, and canine skin fibroblasts were used as a control. Total RNA was extracted using the Total Gold DNA Extraction Kit, and the expression of OCT4, Sox2, and Nanog mRNA was detected by fluorescence quantitative PCR after reverse transcription.

[0162] Table 6 Fluorescence quantitative PCR primer sequence information

[0163]

[0164] Table 7 Reverse transcription reaction system

[0165] Reagents Volume(ul) RNA(1ug) x 4×gDNA wiper Mix 4 RNase-free ddH2O 12-x Total 16

[0166] Reverse transcription program: 42°C, 2 min

[0167]

[0168]

[0169] Reverse transcription process:

[0170] Table 8 Fluorescence quantitative PCR reaction system

[0171] Reagents Volume(ul) cDNA 2 Forward Primer(10uM) 0.8 Reverse Primer(10uM) 0.8 SYBR select Master Mix 10 RNase-free ddH2O 6.4 Total 20

[0172] Fluorescence quantitative PCR process:

[0173] The results are as follows Fig.10 As shown, after pLentG-KOSM infection, the expression level of endogenous stemness gene OCT4 mRNA increased 18 times compared with canine skin fibroblasts, the expression level of SOX2 mRNA increased 11 times compared with canine skin fibroblasts, and there was no significant difference in the expression level of Nanog mRNA. The relative expression level of stemness genes was significantly higher than that of the four-factor separate transfection system and Fuw-Teto-OSKM system.

[0174] In this example, the RNA extraction kit was purchased from Quanshijin Company; the HiScript II Q RT SuperMix for qPCR (+gDNA wiper) reverse transcription kit was purchased from Novartis Company; and the SYBR select Master Mix was purchased from ABI Company.

[0175] Example 11: Embryoid body induction and identification of three germ layers

[0176] 1. Embryoid body induction: The cells identified after proliferation and passage in Example 7 were selected and cultured in a low-adsorption 12-well plate without matrix gel treatment, and RM culture medium was selected for culture; after 7 days of culture, the cells were suspended in the culture plate in a mass form, and photographed; Fig.11 The results show that the canine induced pluripotent stem cells induced by the pLentG-KOSM system form spherical embryoid bodies after being cultured on a low-adsorption plate, indicating that the three germ layers of the canine induced pluripotent stem cells obtained by the present invention have normal morphology and mature tissue structures of the three germ layers.

[0177] 2. Identification of the three germ layers: The formed embryoid bodies were inoculated into a 12-well plate treated with matrix gel and cultured in RM medium for 21 days. The expression of ectoderm marker genes GFAP and βIII-Tubulin, mesoderm marker genes Desmin and ACTA2, and endoderm marker genes AFP and FOXA2 were detected by immunofluorescence. Fig.12 This is a diagram for identifying the three-germ layer differentiation of canine induced pluripotent stem cell embryoid bodies. The results show that after induced differentiation, the embryoid bodies all positively express endoderm marker genes AFP and FOXA2, mesoderm marker genes Desmin and ACTA2, and ectoderm marker genes GFAP and βIII-Tubulin, indicating that the induced pluripotent stem cells obtained by the present invention have the ability to differentiate into three germ layers.

[0178] In this example, GFAP, βIII-Tubulin, Desmin, ACTA2, AFP, and FOXA2 were purchased from ABclonal.

[0179] Example 12: Neural progenitor cell induction

[0180] Induction of neural stem cells: The cells identified after proliferation and subculture in Example 7 were picked up and suspended for culture, and the growth factors B27 and Heparin required for neural stem cells were added. The induction differentiation medium was DMEM / F12+1% SP+20ng / mL B27+FGF+EGF+20ug / mL Heparin.

[0181] After 10 days of induction, the cells formed neurospheres and some of them were found to have antennae. Identification of neural progenitor cells: Immunofluorescence detection of neural progenitor cell markers FOXG1 and PAX6 in induced neural progenitor cells. Figure 14-15 shown.

[0182] In this example, DMEM / F12 and B27 were purchased from gbico, EGF was purchased from peprotech, Heparin was purchased from stemcell, and FOXG1 and PAX6 were purchased from ABclonal.

Claims

1. A method for inducing the transformation of canine skin fibroblasts into pluripotent stem cells, comprising the following steps: S1 Isolation and culture of canine skin fibroblasts; S2 Mycoplasma testing of canine skin fibroblasts confirmed that the fibroblasts were free of mycoplasma infection; S3 lentivirus preparation and pLentG-KOSM titer determination; S4 Lentivirus infection to induce canine pluripotent stem cell formation: The F2 generation canine skin fibroblasts obtained in step S1 are repeatedly infected with the lentivirus containing pLentG-KOSM prepared in step S3, and after infection, they are cultured with a pluripotent stem cell induction culture medium to obtain induced pluripotent stem cells; the pluripotent stem cell induction culture medium is divided into an early pluripotent stem cell culture medium and a late pluripotent stem cell culture medium; S5 detects and identifies the induced pluripotent stem cells obtained by S4.

2. The method of inducing canine skin fibroblasts to transform into pluripotent stem cells according to claim 1, characterized in that: The specific steps of inducing canine pluripotent stem cells through S4 lentivirus infection are as follows: S41. Take F2 canine skin fibroblasts and add 5×10 4 The cells were seeded in a 6-well culture plate and cultured for 12 h. The prepared lentivirus containing pLentG-KOSM was used to infect canine skin fibroblasts at an MOI of 20, and the infection was repeated 24 h later; S42. After infection, 2×10 4 Plated on 6-well plates treated with Matrigel in advance, cultured in RM medium 24 hours after infection; S43. 2-7 days after infection, replace the previous pluripotent stem cell culture medium with the culture medium, and change the medium every 48 hours; S44. 7-21 days after infection, switch to late pluripotent stem cell culture medium, and change the medium every 48 hours until embryonic stem cell-like cell clones appear. Use a mouth pipette to pick up the clones and expand the culture in a 48-well plate treated with matrix gel.

3. The method of inducing canine skin fibroblasts to transform into pluripotent stem cells according to claim 1, characterized in that: The steps of isolating and culturing S1 canine skin fibroblasts are as follows: S11. Collection of skin tissue from domestic dogs: The animals were anesthetized, the skin of the buttocks was disinfected with 75% alcohol, the epidermal hair was cut as much as possible, a small piece of skin tissue was cut, the cut part was disinfected again, and the tissue was soaked in 75% alcohol for 10 seconds, and then washed three times in 1× PBS containing 5% double antibody, and the disinfected and washed tissue was placed in AQIX tissue preservation solution containing 2% double antibody and transported back to the laboratory at 4°C; S12. Tissue pretreatment: After the tissue is transported back to the laboratory, it is washed twice in 1×PBS containing 2% double antibody in a biological safety cabinet, the epidermal hair and fat layer are scraped off with a blade, and the tissue is chopped with sterile scissors; S13. Enzyme digestion method to obtain canine skin fibroblasts: Place the chopped tissue in step S12 into a 50ml centrifuge tube, add about 5 times the volume of 0.25% trypsin digestion solution, and digest in a 37°C water bath for 30-90min. During this period, shake the centrifuge tube several times to ensure that the tissue blocks are fully digested; terminate the digestion with complete cell culture medium containing serum, let it stand for 10min, pass through 200 and 400 mesh cell sieves in turn, centrifuge the suspension at 1000rpm for 10min, resuspend and wash once with DMEM basal culture medium, and centrifuge at 1000rpm for 10min; resuspend with 1ml complete cell culture medium, inoculate in a T25 culture flask, and replace with fresh culture medium every 48 hours until the cells are full.

4. The method of inducing canine skin fibroblasts to transform into pluripotent stem cells according to claim 1, characterized in that: The specific steps of the S3 lentivirus preparation and pLentG-KOSM titer determination are as follows: S31. Resuscitate 293T cells, plate them in 100 mm culture dishes, and transfect when the cell density reaches about 60%. Replace with fresh culture medium before transfection. S32. The plasmid and transfection reagent were mixed at a ratio of 1:1.5-1:4 and added to 293T cells. The transfection reagent was washed off 6 hours after transfection and replaced with fresh culture medium; S33. Collect the virus supernatant 48 and 72 hours after transfection, centrifuge at 1000 rpm for 10 min, and filter the supernatant through a 0.45 uM cell filter; S34.1 volume of 5×PEG8000 was gently mixed with 4 volumes of viral supernatant obtained from S33 and incubated at 4°C overnight; S35.4500g, centrifuge at 4℃ for 20min, discard the supernatant, resuspend in DMEM basal culture medium at 2-3 times the volume of the pellet, aliquot the virus into 100ul, and store at -80℃ for later use; S36.293T cells were collected at 5×10 4 Plated in 12-well plates, virus infection was performed 24 h later, with a culture volume of 1 ml per well; S37. The virus solution was added at a volume of 10, 50, 100, and 200 ul to infect 293T cells. After 48 hours of infection, the 293T cells infected with different pLentG-KOSM virus additions were collected, the cell fluorescence was detected, and the average virus titer was calculated using the formula: (293T GFP% × total number of 293T cells) ÷ added virus volume.

5. The method of inducing canine skin fibroblasts to transform into pluripotent stem cells according to claim 4, characterized in that: The components of the canine skin fibroblast culture solution are as follows: 15% FBS, DMEM basal culture medium, and 1-2% double antibody.

6. The method of inducing canine skin fibroblasts to transform into pluripotent stem cells according to claim 1, characterized in that: The components of the early pluripotent stem cell culture medium are: 10-20% FBS, 0.5-1.5% MEM NEAA, 0.5-1.5% glutamine, 10-20ng / ml FGF, 10-20ng / ml LIF, and DMEM basic culture medium.

7. The method of inducing canine skin fibroblasts to transform into pluripotent stem cells according to claim 6, characterized in that: The components of the early pluripotent stem cell culture medium are: 10% FBS, 1% MEMNEAA, 1% glutamine, 10 ng / ml FGF, 10 ng / ml LIF, and DMEM basic culture medium.

8. The method of inducing canine skin fibroblasts to transform into pluripotent stem cells according to claim 1, characterized in that: The late stage pluripotent stem cell culture medium comprises the following components: 20% 5×Supplement, 10-20ng / ml FGF, 10-20ng / ml LIF, 0.1-0.5uM Pifithrin-μ, 0.5-1uM A83-01, 0.5-1uM Y27632, 0.5-1uM PD0325901, 2-5uM CHIR99021, 200-300uM Sodium Butyrate, and mTeSR basal medium.

9. The method of inducing canine skin fibroblasts to transform into pluripotent stem cells according to claim 8, characterized in that: The late pluripotent stem cell culture medium comprises: 20% 5×Supplement, 10 ng / ml FGF, 10 ng / ml LIF, 0.3 uM Pifithrin-μ, 0.5 uM A83-01, 0.5 uM Y27632, 0.5 uM PD0325901, 3 uM CHIR99021, 250 uM Sodium Butyrate, and mTeSR basal medium.